Breast, Colorectal, Esophageal, Gynecologic, Head and Neck, Kidney, Lung, Lymphoma, Melanoma / Skin, Osteosarcoma, Prostate, Testicular, Urothelial
General Information
The Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Adult
NCT02693535
The Targeted Agent and Profiling Utilization Registry (TAPUR) Study is a non-randomized clinical trial that aims to describe the performance (both safety and efficacy) of commercially available, targeted anticancer drugs prescribed for treatment of patients with advanced cancer that has a potentially actionable genomic variant. The study provides approved targeted therapies that are contributed to the program by collaborating pharmaceutical companies, catalogues the choice of genomic profiling test by clinical oncologists and aims to learn about the utility of registry data to develop hypotheses for additional clinical trials.
Inova Schar Cancer Institute
8081 Innovation Park Drive
Fairfax, VA 22031
A department of Inova Fairfax Hospital
Inova Melanoma and Skin Cancer Center
3299 Woodburn Rd., Suite 320,
Annandale, VA 22003